1. Home
  2. ARTV vs DUOT Comparison

ARTV vs DUOT Comparison

Compare ARTV & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • DUOT
  • Stock Information
  • Founded
  • ARTV 2019
  • DUOT 1990
  • Country
  • ARTV United States
  • DUOT United States
  • Employees
  • ARTV N/A
  • DUOT N/A
  • Industry
  • ARTV
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • ARTV
  • DUOT Technology
  • Exchange
  • ARTV NYSE
  • DUOT Nasdaq
  • Market Cap
  • ARTV 61.9M
  • DUOT 66.3M
  • IPO Year
  • ARTV 2024
  • DUOT N/A
  • Fundamental
  • Price
  • ARTV $1.93
  • DUOT $7.65
  • Analyst Decision
  • ARTV Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • ARTV 7
  • DUOT 2
  • Target Price
  • ARTV $19.17
  • DUOT $11.50
  • AVG Volume (30 Days)
  • ARTV 147.5K
  • DUOT 125.2K
  • Earning Date
  • ARTV 05-08-2025
  • DUOT 05-15-2025
  • Dividend Yield
  • ARTV N/A
  • DUOT N/A
  • EPS Growth
  • ARTV N/A
  • DUOT N/A
  • EPS
  • ARTV N/A
  • DUOT N/A
  • Revenue
  • ARTV N/A
  • DUOT $11,162,390.00
  • Revenue This Year
  • ARTV N/A
  • DUOT $296.46
  • Revenue Next Year
  • ARTV N/A
  • DUOT $43.11
  • P/E Ratio
  • ARTV N/A
  • DUOT N/A
  • Revenue Growth
  • ARTV N/A
  • DUOT 89.27
  • 52 Week Low
  • ARTV $1.78
  • DUOT $2.03
  • 52 Week High
  • ARTV $17.31
  • DUOT $9.27
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • DUOT 53.14
  • Support Level
  • ARTV N/A
  • DUOT $7.00
  • Resistance Level
  • ARTV N/A
  • DUOT $9.27
  • Average True Range (ATR)
  • ARTV 0.00
  • DUOT 0.89
  • MACD
  • ARTV 0.00
  • DUOT 0.02
  • Stochastic Oscillator
  • ARTV 0.00
  • DUOT 35.46

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: